Processing of long-acting natriuretic peptide and vessel dilator in human plasma and serum

Peptides

Volumn 17, Issue 7, 1996, Pages 1155-1162

  Overton, Rose M ^a,b   Vesely, David L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

high performance gel permeation chromatography; long acting natriuretic peptide; metabolic degradation; plasma; serum; vessel dilator

Indexed keywords

EDETIC ACID; NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEGRADATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ATRIAL NATRIURETIC FACTOR; CHROMATOGRAPHY, GEL; HALF-LIFE; HUMANS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 0029906914     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00185-4     Document Type: Article

References (37)

1. 1. Barr, P. J. Mammalian subtilisins: The long-sought dibasic processing endoproteases. Cell 66:1-3; 1991.
2. +-ATPase of the atrial natriuretic peptides. Endocrinology 136:2033-2039; 1995.
3. 3. Dietz, J. R.; Nazian, S. J.; Vesely, D. L. Release of ANF, proANF 1-98, and proANF 31-67 from isolated rat atria by atrial distension. Am J Physiol. 260:H1774-H1778; 1991.
4. 4. Dunn, B. M.; Kay, J. Design, synthesis and analysis of new synthetic substrates for the aspartic proteinases. Biochem. Soc. Trans. 13:1032-1035; 1985.
5. 5. Glazer, A. N.; Smith, E. L. Papin and other plant sulfydral proteolytic enzymes. In: Boyer, P. D., ed. The enzymes, vol. III. Hydrolysis: Peptide bonds. New York: Academic Press; 1971:501.
6. 6. Gower, W. R., Jr.; Chiou, S.; Skolnick, K.; Vesely, D. L. Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 15:861-867; 1994.
7. 7. Gros, C.; Souque, A.; Schwartz, J. C. Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: Role of enkephalinase (EC 3.4.24.11). Peptides 17:1-5; 1990.
8. 2. J. Clin. Invest. 89:1411-1417; 1992.
9. 9. Habibullah, A. A.; Villarreal, D.; Freeman, R. H.; Dietz, J. R.; Vesely, D. L.; Simmons, J. C. Infusion of atrial natriuretic factor prohormone peptides in dogs with experimental heart failure. Clin. Exp. Pharmacol. Physiol. 22:130-135; 1995.
10. 10. Itoh, H.; Nakao, K.; Mukoyama, M.; et al. Secretion of N-terminal fragment of α-human atrial natriuretic polypeptide. Hypertension II(Suppl. 1):52-56; 1988.
11. 2-terminus are natriuretic and/or kaliuretic. Am. J. Physiol. 258:F1401-F1408; 1990.
12. 12. Meleagros, L.; Gibbs, J. S. R.; Ghatei, M. A.; Bloom, S. R. Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. Br. Heart J. 60:39-44; 1988.
13. 13. Nakao, K.; Sugawara, A.; Morri, N.; Sakamoto, M.; Yamada, T. The pharmacokinetics of α-human atrial natriuretic polypeptide in healthy subjects. Eur. J. Clin. Pharmacol. 31:101-103; 1986.
14. 14. Ngo, L.; Wyeth, R. P.; Bissett, J. K.; et al. Prohormone atrial natriuretic peptides 1-30, 31-67, and 99-126 increase in proportion to right ventricular pacing rate. Am. Heart J. 117:385-390; 1989.
15. 15. Ngo, L.; Bissett, J. K.; Winters, C. J.; Vesely, D. L. Plasma prohormone atrial natriuretic peptides 1-98 and 31-67 increase with supraventricular and ventricular arrhythmias. Am. J. Med. Sci. 300:71-77; 1990.
16. 16. Overton, R. M.; Vesely, D. L. Processing of kaliuretic peptide in human plasma and serum. Peptides 17:1041-1046; 1996.
17. 17. Pearl, L.; Blundell, T. The active site of aspartic proteinases. FEBS Lett. 174:96-101; 1984.
18. 18. Poulos, J. E.; Gower, W. R., Jr.; Friedl, F. E.; Vesely, D. L. Atrial natriuretic peptide gene expression within invertebratic hearts. Gen. Comp. Endocrinol. 100:61-68; 1995.
19. 19. Seidah, N. G.; Chrétien, M.; Day, R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: Divergent or shared functions. Biochimie 76:197-209; 1994.
20. 20. Tan, A. C. I. T. L.; Russel, F. G. M.; Thien, T.; Benraad, T. J. Atrial natriuretic peptide: An overview of clinical pharmacology and pharmacokinetics. Clin. Pharmacokinet. 24:28-45; 1993.
21. 21. Van de Ven, W. J. M.; Roebroek, A. J. M.; Van Duijnhoven, H. L. P. Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases. Crit. Rev. Oncogenesis 4(2):115-136; 1993.
22. 22. Vesely, D. L. Atrial natriuretic hormones. Englewood Cliffs, NJ: Prentice Hall, Inc.; 1992:1-256.
23. 23. Vesely, D. L. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone. Clin. Exp. Pharmacol. Physiol. 22:108-114; 1995.
24. 24. Vesely, D. L.; Chiou, S.; Douglas, M. A.; McCormick, M. T.; Rodriguez-Paz, G.; Schocken, D. D. Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion. J. Endocrinol. 146:383-380; 1995.
25. 25. Vesely, D. L.; Douglass, M. A.; Dietz, J. R.; et al. Negative feedback of atrial natriuretic peptides. J. Clin. Endocrinol. Metab. 78:1128-1134; 1994.
26. 26. Vesely, D. L.; Douglass, M. A.; Dietz, J. R.; et al. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans. Circulation 90:1129-1140; 1994.
27. 27. Vesely, D. L.; Giordano, A. T. Food intake and body positional change alter the circadian rhythm of atrial natriuretic peptides excretion into human urine. Chronobiol. Int. 8:373-384; 1991.
28. 28. Vesely, D. L.; Gower, W. R., Jr.; Giordano, A. T.; Friedl, F. E. Atrial natriuretic peptides in the heart and hemolymph of the oyster, Crassostrea virginica: A comparison with vertebrates. Comp. Biochem. Physiol. [B] 106:535-546; 1993.
29. 29. Vesely, D. L.; Noms, J. S.; Walters, J. M.; Jespersen, R. R.; Baeyens, D. A. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. Biochem. Biophys. Res. Commun. 148:1540-1548; 1987.
30. 30. Vesely, D. L.; Norsk, P.; Gower, W R. Jr.; Chiou, S.; Epstein, M. Release of kaliuretic peptide during immersion-induced central hypervolemia in healthy humans. Proc. Soc. Exp. Biol. Med. 209:20-26; 1995.
31. 31. Vesely, D. L.; Norsk, P.; Winters, C. J.; Rico, D. M.; Sallman, A. L.; Epstein, M. Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans. Proc. Soc. Exp. Biol. Med. 192:230-235; 1989.
32. 32. Vesely, D. L.; Preston, R.; Gower, W. R. Jr.; Chiou, S.; Epstein, M. Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans. Am. J. Nephrol. 16:128-137; 1996.
33. 33. Winters, C. J.; Sallman, A. L.; Baker, B. J.; Meadows, J.; Rico, D. M.; Vesely, D. L. The N-terminus and a 4000 molecular weight peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in man and increase in congestive heart failure. Circulation 80:438-449; 1989.
34. 34. Winters, C. J.; Sallman, A. L.; Vesely, D. L. Circadian rhythm of prohormone atrial natriuretic peptides 1-30, 31-67, and 99-126 in man. Chronobiol. Int. 5:403-409; 1988.
35. 35. Winters, C. J.; Sallman, A. L.; Meadows, J.; Rico, D. M.; Vesely, D. L. Two new hormones: Prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man. Biochem. Biophys. Res. Commun. 150:231-236; 1988.
36. 36. Yandle, T. G.; Espiner, E. A.; Nicholls, M. G.; Duff, H. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J. Clin. Endocrinol. Metab. 63:72-79; 1986.
37. 37. Yandle, T. G.; Richards, A. M.; Nicholls, M. G.; Cuneo, R.; Espiner, E. A.; Livesey, J. H. Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci. 38:1827-1833; 1986.